Is a complete AXSM research report available?

No complete published report is available for Axsome Therapeutics, Inc. (AXSM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · USD

$241

-0.53 (-0.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AXSM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	12.4B
Revenue (ttm)	708.2M
Net income (ttm)	-188.3M
EPS (ttm)	-$3.74
Shares out	51.5M
Volume	461,840
Beta	0.60
Price target	$282	+16.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 708.2M
Net income (ttm): -188.3M
EPS (ttm): -$3.74
Market cap: 12.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All AXSM indicators

Market & fundamental data

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001579428
Company name	Axsome Therapeutics, Inc.
Country	United States
Country code	US
Cusip	05464T104
Employees	1,220
Employees Change	508%
Employees Change Percent	71.35
Enterprise value	$12.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-11-19
Isin	US05464T1043
Last refreshed	2026-07-27
Market cap	$12.4B
Market cap category	Large-Cap
Price	$241
Price currency	USD
Rev Per Employee	580,521.31x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	AXSM
Website	https://www.axsome.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.52%
EV Sales Forward	11.33x
EV/Sales	17.39x
FCF yield	-0.57%
P/B ratio	227.02x
P/S ratio	17.51x
PS Forward	11.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-24.45%
EBITDA Margin	-23.13%
Gross margin	92.6%
Gross Profit	$655.8M
Gross Profit Growth	65.88%
Gross Profit Growth Q	58.03%
Gross Profit Growth3 Y	70.22%
Net Income	$-188.3M
Net Income Growth Years	1%
Pretax Margin	-26.66%
Profit Margin	-26.59%
Profit Per Employee	$-154,347
ROA	-16.84
Roa5y	-35.63
ROCE	-63.1
ROE	-349.4
Roe5y	-228.7
ROIC	-40.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	41.01%
Cagr1y	126.72%
Cagr3y	47.46%
Cagr5y	35.04%
EPS Growth Years	1
Revenue Growth	63.88x
Revenue Growth Q	57.42x
Revenue Growth Quarters	8x
Revenue Growth Years	3x
Revenue Growth3 Y	69.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.08
Assets	$713.6M
Cash	$305.1M
Current Assets	$611.2M
Current Liabilities	$439.2M
Debt	$219.9M
Debt Equity	$4.03
Equity	$54.6M
Interest Coverage	-12.58
Liabilities	$659M
Long Term Assets	$102.4M
Long Term Liabilities	$219.8M
Net Cash	$85.2M
Net Cash By Market Cap	$0.69
Net Cash Growth	-4.99%
Net Debt Equity	$-1.56
Tangible Book Value	$3.6M
Tangible Book Value Per Share	$0.07
WACC	7.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.39
Inventory Turnover	2.19
Net Working Capital	$-59.3M
Quick ratio	1.27
Working Capital	$172M
Working Capital Turnover	$3.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.24%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	3,005.67%
1Y total return	126.59%
200-day SMA	182.5
3Y total return	220.74%
50-day SMA	238.5
50-day SMA vs 200-day SMA	50over200
5Y total return	348.96%
All Time High	260.2
All Time High Change	-7.38%
All Time High Date	2026-06-18
All Time Low	1.94
All Time Low Change	12,322.68%
All Time Low Date	2018-12-27
ATR	9.32
Beta	0.6
Beta1y	0.36
Beta2y	0.82
Ch YTD	31.95
High	243
High52	260.2
High52 Date	2026-06-18
High52ch	-7.38%
Low	237.8
Low52	96.09
Low52 Date	2025-08-04
Low52ch	150.81%
Ma50ch	1.04%
Premarket Change Percent	0.19
Premarket Price	$242
Premarket Volume	1,606
Price vs 200-day SMA	32.08%
RSI	52.65
RSI Monthly	78.66
RSI Weekly	68.2
Sharpe ratio	2.05x
Sortino ratio	4.38
Total Return	-4.24%
Tr YTD	31.95
Tr1m	-0.4%
Tr1w	4.78%
Tr3m	31.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	21
Analyst Count Top	17
Analyst Price Target Top	$283
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.86
Earnings Revenue Estimate	222,285,248x
Earnings Revenue Estimate Growth	48.15x
Operating Income	$-176.5M
Operating margin	-24.93
Price target	$282
Price Target Change	$16.93
Price Target Change Top	$17.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	43,556,452%
Float Percent	84.64%
Net Borrowing	-4,383,000
Shares Insiders	1.08%
Shares Institutions	75.56%
Shares Out	51,459,766
Shares Qo Q	1.12%
Shares Yo Y	4.24%
Short Float	6.05%
Short Ratio	2.29
Short Shares	5.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-164.9M
Average Volume	1,142,267x
Bv Per Share	1.06
CAPEX	$-263,000
Ch10y	3,005.7
Ch1m	-0.4
Ch1w	4.78
Ch1y	126.6
Ch3m	31.9
Ch3y	220.7
Ch5y	349
Ch6m	29.6
Change	-0.22%
Change From Open	0.03
Close	241.5
Days Gap	-0.25
Depreciation Amortization	9,298,000
Dollar Volume	111,303,440
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-173.1M
EBITDA	$-163.8M
EPS	$-3.74
F Score	4
FCF	$-71M
FCF EV Yield	-0.58x
FCF Per Share	$-1.38
Financing CF	75,189,000
Fiscal Year End	December
Founded	2,012
Goodwill	12,042,000
Income Tax	$-530,000
Investing CF	-263,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-23
Ma150	197.2
Ma150ch	22.21%
Ma20	239.1
Ma20ch	0.79%
Net CF	4,196,000
Next Earnings Date	2026-08-10
Open	240.9
Optionable	Yes
Position In Range	62.16
Post Close	241
Postmarket Change Percent	-0.83
Postmarket Price	$239
Ppne	20,581,000
Pre Close	241.5
Price Date	2026-07-24
Ptbv Ratio	3,446.9
Relative Volume	0.4x
Revenue	708,236,000x
SBC By Revenue	13.26x
Share Based Comp	93,882,000
Tax By Revenue	-0.07x
Tr6m	29.6%
Us State	New York
Volume	461,840
Z Score	3.81

Axsome Therapeutics, Inc. (AXSM)

Coverage state: Market snapshot only — no published research

Generate the first AXSM analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · AXSM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AXSM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AXSM

Frequently asked questions